Login to Your Account



Financings Roundup


Tuesday, September 11, 2012
• Regulus Therapeutics Inc., of La Jolla, Calif., set terms for its initial public offering (IPO), planning to raise $50 million by offering 4.5 million shares in the price range of $10 to $12.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription